Work

Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation

Year: 2020

Type: article

Source: Circulation Heart Failure

DOI: 10.1161/circheartfailure.119.006696

Authors: Emily K. Zern, Susan Cheng, Aaron M. Wolfson, Michele A. Hamilton, Michael R. Zile, Scott D. Solomon, Michelle M. Kittleson

Institutions: Cedars-Sinai Medical Center, Cedars-Sinai Smidt Heart Institute, University of Arizona, Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Brigham and Women's Hospital

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Heart, Lung, and Blood Institute

Awards: Mediators of Systemic Inflammation and Heart Failure Risk in the Community, Inflammatory Mediators, Cardiovascular Health, and Longevity in Women, Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2

OpenAlex ID: W3006653371

FWCI: 3.233

Cites: 6

Cited by: 36

Related to: 10